secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-09-22T23:59:59+00:00
Accession:  0001213900-25-090107
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERO Therapeutics updates investor presentation with no material new disclosures
--------------------------------------------------------------------------------

- Company furnished updated corporate presentation dated September 2025 as Exhibit 99.1, intended for investor meetings.
- No financial results, clinical updates, or guidance were included in the filing or the attached exhibit text.
- Presentation available on company website but substantive content not extracted from the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025090107/0001213900-25-090107-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025090107/ea0258166-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-090107

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer